Logo image of MNTK

MONTAUK RENEWABLES INC (MNTK) Stock Fundamental Analysis

NASDAQ:MNTK - US61218C1036 - Common Stock

2.11 USD
+0.02 (+0.96%)
Last: 9/3/2025, 8:00:01 PM
2.11 USD
0 (0%)
After Hours: 9/3/2025, 8:00:01 PM
Fundamental Rating

4

Overall MNTK gets a fundamental rating of 4 out of 10. We evaluated MNTK against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. While MNTK is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, MNTK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MNTK had positive earnings in the past year.
MNTK had a positive operating cash flow in the past year.
MNTK had positive earnings in 4 of the past 5 years.
In the past 5 years MNTK always reported a positive cash flow from operatings.
MNTK Yearly Net Income VS EBIT VS OCF VS FCFMNTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

MNTK has a Return On Assets (0.69%) which is comparable to the rest of the industry.
The Return On Equity of MNTK (1.04%) is comparable to the rest of the industry.
MNTK has a Return On Invested Capital of 3.52%. This is in the better half of the industry: MNTK outperforms 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MNTK is above the industry average of 4.22%.
The 3 year average ROIC (7.97%) for MNTK is well above the current ROIC(3.52%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.69%
ROE 1.04%
ROIC 3.52%
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)7.97%
ROIC(5y)5.37%
MNTK Yearly ROA, ROE, ROICMNTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

MNTK has a Profit Margin (1.46%) which is in line with its industry peers.
In the last couple of years the Profit Margin of MNTK has remained more or less at the same level.
MNTK's Operating Margin of 7.86% is in line compared to the rest of the industry. MNTK outperforms 45.00% of its industry peers.
In the last couple of years the Operating Margin of MNTK has declined.
MNTK's Gross Margin of 41.76% is on the low side compared to the rest of the industry. MNTK is outperformed by 60.00% of its industry peers.
In the last couple of years the Gross Margin of MNTK has remained more or less at the same level.
Industry RankSector Rank
OM 7.86%
PM (TTM) 1.46%
GM 41.76%
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
MNTK Yearly Profit, Operating, Gross MarginsMNTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MNTK is destroying value.
Compared to 1 year ago, MNTK has more shares outstanding
MNTK has more shares outstanding than it did 5 years ago.
MNTK has a better debt/assets ratio than last year.
MNTK Yearly Shares OutstandingMNTK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
MNTK Yearly Total Debt VS Total AssetsMNTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

MNTK has an Altman-Z score of 2.15. This is not the best score and indicates that MNTK is in the grey zone with still only limited risk for bankruptcy at the moment.
MNTK has a Altman-Z score of 2.15. This is amongst the best in the industry. MNTK outperforms 85.00% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that MNTK is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.23, MNTK belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 2.15
ROIC/WACC0.42
WACC8.36%
MNTK Yearly LT Debt VS Equity VS FCFMNTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

MNTK has a Current Ratio of 0.77. This is a bad value and indicates that MNTK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.77, MNTK is doing worse than 65.00% of the companies in the same industry.
MNTK has a Quick Ratio of 0.77. This is a bad value and indicates that MNTK is not financially healthy enough and could expect problems in meeting its short term obligations.
MNTK's Quick ratio of 0.77 is in line compared to the rest of the industry. MNTK outperforms 55.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.77
MNTK Yearly Current Assets VS Current LiabilitesMNTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

MNTK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -83.33%.
MNTK shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.33% yearly.
MNTK shows a decrease in Revenue. In the last year, the revenue decreased by -1.78%.
Measured over the past years, MNTK shows a quite strong growth in Revenue. The Revenue has been growing by 10.70% on average per year.
EPS 1Y (TTM)-83.33%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-300%
Revenue 1Y (TTM)-1.78%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%4.13%

3.2 Future

MNTK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.59% yearly.
MNTK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.17% yearly.
EPS Next Y-128.34%
EPS Next 2Y-52.4%
EPS Next 3Y15.23%
EPS Next 5Y20.59%
Revenue Next Year-12.54%
Revenue Next 2Y-4.68%
Revenue Next 3Y9.17%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MNTK Yearly Revenue VS EstimatesMNTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
MNTK Yearly EPS VS EstimatesMNTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.1 0.2 0.3

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 105.50, which means the current valuation is very expensive for MNTK.
The rest of the industry has a similar Price/Earnings ratio as MNTK.
MNTK is valuated expensively when we compare the Price/Earnings ratio to 26.84, which is the current average of the S&P500 Index.
MNTK is valuated quite expensively with a Price/Forward Earnings ratio of 155.19.
MNTK's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.48. MNTK is valued rather expensively when compared to this.
Industry RankSector Rank
PE 105.5
Fwd PE 155.19
MNTK Price Earnings VS Forward Price EarningsMNTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MNTK is valued cheaper than 90.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.56
MNTK Per share dataMNTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

MNTK's earnings are expected to grow with 15.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)9.31
EPS Next 2Y-52.4%
EPS Next 3Y15.23%

0

5. Dividend

5.1 Amount

MNTK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MONTAUK RENEWABLES INC

NASDAQ:MNTK (9/3/2025, 8:00:01 PM)

After market: 2.11 0 (0%)

2.11

+0.02 (+0.96%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners17.32%
Inst Owner Change-3.8%
Ins Owners54%
Ins Owner Change0%
Market Cap300.17M
Analysts44.44
Price Target2.89 (36.97%)
Short Float %1.89%
Short Ratio6.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-256.86%
Min EPS beat(2)-413.72%
Max EPS beat(2)-100%
EPS beat(4)1
Avg EPS beat(4)-178.43%
Min EPS beat(4)-413.72%
Max EPS beat(4)23.84%
EPS beat(8)2
Avg EPS beat(8)-100.04%
EPS beat(12)2
Avg EPS beat(12)-95.9%
EPS beat(16)3
Avg EPS beat(16)-50.04%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-1.5%
Max Revenue beat(2)1.62%
Revenue beat(4)2
Avg Revenue beat(4)-11.47%
Min Revenue beat(4)-51.79%
Max Revenue beat(4)5.8%
Revenue beat(8)2
Avg Revenue beat(8)-12.26%
Revenue beat(12)3
Avg Revenue beat(12)-13.27%
Revenue beat(16)6
Avg Revenue beat(16)-6.15%
PT rev (1m)0%
PT rev (3m)-9.2%
EPS NQ rev (1m)-85.2%
EPS NQ rev (3m)-95.24%
EPS NY rev (1m)-127.78%
EPS NY rev (3m)-119.61%
Revenue NQ rev (1m)-1.59%
Revenue NQ rev (3m)-39.08%
Revenue NY rev (1m)1.21%
Revenue NY rev (3m)-0.49%
Valuation
Industry RankSector Rank
PE 105.5
Fwd PE 155.19
P/S 1.66
P/FCF N/A
P/OCF 6.43
P/B 1.18
P/tB 1.28
EV/EBITDA 8.56
EPS(TTM)0.02
EY0.95%
EPS(NY)0.01
Fwd EY0.64%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.33
OCFY15.54%
SpS1.27
BVpS1.79
TBVpS1.65
PEG (NY)N/A
PEG (5Y)9.31
Profitability
Industry RankSector Rank
ROA 0.69%
ROE 1.04%
ROCE 4.36%
ROIC 3.52%
ROICexc 3.86%
ROICexgc 4.14%
OM 7.86%
PM (TTM) 1.46%
GM 41.76%
FCFM N/A
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)7.97%
ROIC(5y)5.37%
ROICexc(3y)11.17%
ROICexc(5y)7.39%
ROICexgc(3y)12.1%
ROICexgc(5y)8%
ROCE(3y)9.89%
ROCE(5y)6.65%
ROICexcg growth 3Y40.95%
ROICexcg growth 5Y0.62%
ROICexc growth 3Y41%
ROICexc growth 5Y0.44%
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 1.45
Cap/Depr 261.66%
Cap/Sales 36.87%
Interest Coverage 3.21
Cash Conversion 117.21%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.77
Altman-Z 2.15
F-Score4
WACC8.36%
ROIC/WACC0.42
Cap/Depr(3y)223.62%
Cap/Depr(5y)158.87%
Cap/Sales(3y)27.46%
Cap/Sales(5y)21.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.33%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-300%
EPS Next Y-128.34%
EPS Next 2Y-52.4%
EPS Next 3Y15.23%
EPS Next 5Y20.59%
Revenue 1Y (TTM)-1.78%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%4.13%
Revenue Next Year-12.54%
Revenue Next 2Y-4.68%
Revenue Next 3Y9.17%
Revenue Next 5YN/A
EBIT growth 1Y-50.01%
EBIT growth 3Y53.64%
EBIT growth 5Y5.49%
EBIT Next Year1.43%
EBIT Next 3Y18.13%
EBIT Next 5Y3.8%
FCF growth 1Y-247.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.73%
OCF growth 3Y0.71%
OCF growth 5Y9.49%